Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Selling Congress On DTC User Fees: AstraZeneca Uses Guilt

Executive Summary

AstraZeneca U.S. CEO Tony Zook wants Congress to understand the company's "disappointment" in the failure of FDA's user fee program for direct-to-consumer advertising to get off the ground. The system is "good for patients, good public policy, and a sensible way to help alleviate concerns that have been expressed about the tone and content of some DTC," Zook says in an April 24 letter to the leadership of the Senate Health and House Commerce Committees.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts